newsfilter
← Latest News
Business Wire·

ImmunoGen Announces Conference Call to Discuss Its Third Quarter 2023 Operating Results

ImmunoGen Inc. (NASDAQ:IMGN), a leader in the expanding field of antibody-drug conjugates (ADCs) for the treatment of cancer, today announced that the Company will host a conference call at 8:00 a.m. ET on Thursday,